Tikun Olam Cannbit Pharmaceuticals Ltd

XTAE:TKUN (Israel)  
₪ 0.30 (+4.51%) Apr 18
At Loss
P/B:
0.60
Market Cap:
₪ 24.36M ($ 6.48M)
Enterprise V:
₪ 37.77M ($ 10.04M)
Volume:
245.43K
Avg Vol (2M):
206.34K
Also Trade In:
Volume:
245.43K
At Loss

Business Description

Description
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.
Name Current Vs Industry Vs History
Cash-To-Debt 0.33
Equity-to-Asset 0.53
Debt-to-Equity 0.49
Debt-to-EBITDA -0.61
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.5
Distress
Grey
Safe
Beneish M-Score -5.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate -26.7
3-Year FCF Growth Rate 10.8
3-Year Book Growth Rate -15.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 74.47
9-Day RSI 62.48
14-Day RSI 54.95
6-1 Month Momentum % -22.7
12-1 Month Momentum % -48.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.85
Quick Ratio 0.5
Cash Ratio 0.23
Days Inventory 143.13
Days Sales Outstanding 84.41
Days Payable 39.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.5
Shareholder Yield % -30.11
Name Current Vs Industry Vs History
Gross Margin % -3.97
Operating Margin % -64.38
Net Margin % -200.97
FCF Margin % -9.31
ROE % -120.92
ROA % -80.71
ROIC % -28.12
ROC (Joel Greenblatt) % -155.25
ROCE % -113.77

Financials

XTAE:TKUN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tikun Olam Cannbit Pharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₪) 44.228
EPS (TTM) (₪) -1.41
Beta 0
Volatility % 90.87
14-Day RSI 54.95
14-Day ATR (₪) 0.02376
20-Day SMA (₪) 0.2806
12-1 Month Momentum % -48.61
52-Week Range (₪) 0.23 - 0.566
Shares Outstanding (Mil) 80.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tikun Olam Cannbit Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Tikun Olam Cannbit Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price(₪)
No Event Data

Tikun Olam Cannbit Pharmaceuticals Ltd Frequently Asked Questions

What is Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN)'s stock price today?
The current price of XTAE:TKUN is ₪0.30. The 52 week high of XTAE:TKUN is ₪0.57 and 52 week low is ₪0.23.
When is next earnings date of Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN)?
The next earnings date of Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN) is .
Does Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN) pay dividends? If so, how much?
Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN) does not pay dividend.

Press Release

Subject Date
No Press Release